Oncopeptides AB (publ) (STO:ONCO)
Sweden · Delayed Price · Currency is SEK 1.734
-0.004 (-0.23%)
Oct 20, 2026, 9:17 AM CET
Oncopeptides AB Market Cap
Oncopeptides AB has a market cap or net worth of 685.43 million as of October 19, 2026. It is the 27,826th most valuable company in the world and the 349th biggest in Sweden. Its market cap has decreased by 51.38% in one year.
Market Cap
685.43M
Enterprise Value
662.99M
Revenue
95.15M
Global Rank
Country Rank
#349 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since February 22, 2017, Oncopeptides AB's market cap has decreased from 1.67B to 685.43M, a decrease of -58.95%. That is a compound annual growth rate of -8.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 702.43M | -46.39% |
| Dec 30, 2025 | 1.31B | 291.35% |
| Dec 30, 2024 | 334.83M | -53.79% |
| Dec 29, 2023 | 724.64M | -36.76% |
| Dec 30, 2022 | 1.15B | 81.18% |
| Dec 30, 2021 | 632.45M | -94.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Flerie AB | 1.32B |
| Infant Bacterial Therapeutics AB | 1.06B |
| AlzeCure Pharma AB | 979.07M |
| SynAct Pharma AB | 951.97M |
| Medivir AB | 904.85M |
| Xspray Pharma AB | 509.25M |
| FluoGuide | 500.29M |
| Sprint Bioscience AB | 374.58M |